John B. Henneman III - Jun 16, 2021 Form 4 Insider Report for Anika Therapeutics, Inc. (ANIK)

Role
Director
Signature
/s/ John B. Henneman, III
Stock symbol
ANIK
Transactions as of
Jun 16, 2021
Transactions value $
$0
Form type
4
Date filed
6/21/2021, 04:15 PM
Previous filing
Jun 4, 2021
Next filing
Jul 1, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANIK Common Stock Award $0 +4.17K +36.89% $0.00 15.5K Jun 16, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares represent restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Anika Therapeutics, Inc. common stock. The restricted stock units vest in full on the earlier of the 2022 annual meeting of the Company's stockholders or June 16, 2022.